Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Roxana Mehran Robert A Harrington A Michael Lincoff John H. Alexander John J. P. Kastelein Serge Korjian Pierluigi Tricoci Yazan Daaboul Philippe Gabriel Steg Maciej Zarebinski |
| Publication date | November 15, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |